Javascript must be enabled to continue!
Full green assay of rosuvastatin utilizing sulphophtalein dyes: application to tablet analysis
View through CrossRef
The aim of the work was to develop a «green» and extraction-free spectrophotometric procedure for the assay of rosuvastatin in tablets. The present work describes three new spectrophotometric procedures (A, B and C) that can be utilized for routine quality control of rosuvastatin in laboratories.
Materials and methods. Analytical instrumentation: Shimadzu UV-1800 double beam UV-vis spectrophotometer (Japan) with attached UV-Probe ver. 2.62 software, RAD WAG AS 200/C precise analytical balance (Poland). Rosuvastatin calcium (purity ≥98 % (HPLC)) was bought from Sigma-Aldrich Chemicals Co. (St. Louis, MO, USA). Rosuvastatin 10 mg tablets were acquired from a nearby drugstore. All solvents used in this study, including methanol, ethanol, chloroform, acetonitrile and ethyl acetate, were produced by Honeywell and had a purity of 99.9 %. BCG, BCP and BTB were acquired from Sigma-Aldrich Chemicals Co. (USA, St. Louis). All chemicals utilized in the experiment were of analytical purity.
Results and discussion. New simple «green» and extraction-free spectrophotometric procedures for assay of rosuvastatin in tablets involve the formation of ion-pair complexes with sulphophtalein dyes (BCG (Method A), BCP (Method B), BTB (Method C)) have been developed. The absorbances of the coloured reaction products were registered at 405 nm (Method A) and 400 nm (Methods B, C). The concentration was linearly proportional to absorbance values in the range of 2.51-20.08 μg/mL (method A), 2.50-24.90 μg/mL (method B) and 2.51-12.56 μg/mL (method C). Estimation of LOD and LOQ parameters were obtained as 0.67 μg/mL and 2.23 μg/mL (Method A), 0.39 μg/mL and 1.32 μg/mL (Method B), 0.30 μg/mL and 1.01 μg/mL (Method C). The stoichiometric ratio of the reactive components of rosuvastatin - BCG, BCP, and BTB corresponded 1: 1. The %RSD values of intra-day and inter-day were obtained less than < 1.5 %, which showed excellent repeatability and RE % data was ≤ 3 %. The effect on the environment of the proposed spectrophotometric procedures and their compliance with the GAC principles were endorsed by the output of AGREE, GAPI, and AES metrics tools. The values of these three «green» metrics show that the proposed spectrophotometric procedures had a low environmental impact compared with the reported ones.
Conclusions. The developed fast, simple and cost-effective methods A, B, and C can be used for routine analysis of rosuvastatin in tablets
Private Company Technology Center
Title: Full green assay of rosuvastatin utilizing sulphophtalein dyes: application to tablet analysis
Description:
The aim of the work was to develop a «green» and extraction-free spectrophotometric procedure for the assay of rosuvastatin in tablets.
The present work describes three new spectrophotometric procedures (A, B and C) that can be utilized for routine quality control of rosuvastatin in laboratories.
Materials and methods.
Analytical instrumentation: Shimadzu UV-1800 double beam UV-vis spectrophotometer (Japan) with attached UV-Probe ver.
2.
62 software, RAD WAG AS 200/C precise analytical balance (Poland).
Rosuvastatin calcium (purity ≥98 % (HPLC)) was bought from Sigma-Aldrich Chemicals Co.
(St.
Louis, MO, USA).
Rosuvastatin 10 mg tablets were acquired from a nearby drugstore.
All solvents used in this study, including methanol, ethanol, chloroform, acetonitrile and ethyl acetate, were produced by Honeywell and had a purity of 99.
9 %.
BCG, BCP and BTB were acquired from Sigma-Aldrich Chemicals Co.
(USA, St.
Louis).
All chemicals utilized in the experiment were of analytical purity.
Results and discussion.
New simple «green» and extraction-free spectrophotometric procedures for assay of rosuvastatin in tablets involve the formation of ion-pair complexes with sulphophtalein dyes (BCG (Method A), BCP (Method B), BTB (Method C)) have been developed.
The absorbances of the coloured reaction products were registered at 405 nm (Method A) and 400 nm (Methods B, C).
The concentration was linearly proportional to absorbance values in the range of 2.
51-20.
08 μg/mL (method A), 2.
50-24.
90 μg/mL (method B) and 2.
51-12.
56 μg/mL (method C).
Estimation of LOD and LOQ parameters were obtained as 0.
67 μg/mL and 2.
23 μg/mL (Method A), 0.
39 μg/mL and 1.
32 μg/mL (Method B), 0.
30 μg/mL and 1.
01 μg/mL (Method C).
The stoichiometric ratio of the reactive components of rosuvastatin - BCG, BCP, and BTB corresponded 1: 1.
The %RSD values of intra-day and inter-day were obtained less than < 1.
5 %, which showed excellent repeatability and RE % data was ≤ 3 %.
The effect on the environment of the proposed spectrophotometric procedures and their compliance with the GAC principles were endorsed by the output of AGREE, GAPI, and AES metrics tools.
The values of these three «green» metrics show that the proposed spectrophotometric procedures had a low environmental impact compared with the reported ones.
Conclusions.
The developed fast, simple and cost-effective methods A, B, and C can be used for routine analysis of rosuvastatin in tablets.
Related Results
Rosuvastatin Alone or With Extended‐Release Niacin: A New Therapeutic Option for Patients With Combined Hyperlipidemia
Rosuvastatin Alone or With Extended‐Release Niacin: A New Therapeutic Option for Patients With Combined Hyperlipidemia
Combination therapy with a statin and niacin may provide optimal therapy for patients with combined hyperlipidemia and low levels of highdensity lipoprotein (HDL) cholesterol. The ...
Is rosuvastatin protective against sepsis associated encephalopathy? A secondary analysis of the SAILS trial
Is rosuvastatin protective against sepsis associated encephalopathy? A secondary analysis of the SAILS trial
Abstract
Background
Sepsis is a common cause of death in emergency departments and sepsis associated encephalopathy is a major complication of sepsis. Rosuvastatin may hav...
Perbandingan Beberapa Bahan Pengisi pada Formulasi Tablet Hisap
Perbandingan Beberapa Bahan Pengisi pada Formulasi Tablet Hisap
Abstrak. Tablet hisap adalah tablet padat yang mengandung satu atau lebih bahan obat. Biasanya tablet hisap ini memiliki rasa dan aroma yang manis sehingga dapat larut perlahan dal...
Extraction of Dyes from Parts of the Plants and their Phytochemical Screening
Extraction of Dyes from Parts of the Plants and their Phytochemical Screening
The primary goal of obtaining dyes from natural plant sources is to prevent pollution of the environment. Any color, pigment or material originating from organic materials plants, ...
Structural and In-Vitro Characterization of Highly Swellable Β-Cyclodextrin Polymeric Nanogels Fabricated by Free Radical Polymerization for Solubility Enhancement of Rosuvastatin
Structural and In-Vitro Characterization of Highly Swellable Β-Cyclodextrin Polymeric Nanogels Fabricated by Free Radical Polymerization for Solubility Enhancement of Rosuvastatin
Basic aim of the study was to potentiate solubility of Rosuvastatin by loading it in synthesized nanogels. A set of nine different formulations was fabricated by an optimized free ...
GW24-e0760 Effects of rosuvastatin on rats with dyslipidemia and antiatherosclerotic
GW24-e0760 Effects of rosuvastatin on rats with dyslipidemia and antiatherosclerotic
Objectives
To explore the regulating lipid effects of Rosuvastatin on rats with dyslipidemia and its antiatherosclerotic effects.
...
Comparison Between Atorvastatin and Rosuvastatin on Anti- Thrombogenic Effect in Patients with Hyperlipidemia
Comparison Between Atorvastatin and Rosuvastatin on Anti- Thrombogenic Effect in Patients with Hyperlipidemia
Background: Atorvastatin and rosuvastatin are two widely used HMG-CoA reductase inhibitors (statins). These are used as lipid-lowering drugs to reduce atherosclerosis-induced cardi...
Entanglement of AGE-RAGE axis in cardiac pathosis
Entanglement of AGE-RAGE axis in cardiac pathosis
Abstract
Cardiovascular diseases are the major cause of death globally. Acute coronary syndrome is one of numerous cardiovascular illnesses, including advanced glyc...

